InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 12.05
-0.07 (-0.58%)
Nov 10, 2026, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 25.65 billion as of November 9, 2026. It is the 4,858th most valuable company in the world and the 243rd biggest in Hong Kong. Its market cap has decreased by 4.94% in one year.
Market Cap
25.65B
Enterprise Value
20.55B
Revenue
3.93B
Global Rank
Country Rank
#243 Hong Kong
PE Ratio
13.43
ChartMarket Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 25.65B, an increase of 108.87%. That is a compound annual growth rate of 11.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 25.65B | 8.27% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 69.28B |
| RemeGen | 54.09B |
| 3SBio | 37.83B |
| Biocytogen Pharmaceuticals (Beijing) | 35.57B |
| Shanghai Junshi Biosciences | 31.81B |
| Shanghai Henlius Biotech | 26.73B |
| Zai Lab | 22.46B |
| InSilico Medicine Cayman TopCo | 21.57B |